Literature DB >> 9267844

Naked DNA transport and expression in mammalian cells.

J A Wolff1.   

Abstract

The tremendous promise of gene therapy is stymied by inefficient gene transfer. Non-viral methods of transferring genes directly into tissues in situ have great potential for solving this problem. One attractive approach for non-viral direct gene transfer is the use of naked DNA. Previously, it was thought that naked DNA was able to express in only muscle and at low efficiency. We have recently found that naked DNA delivered intraportally can express at high levels in hepatocytes. Other non-viral methods of gene transfer are under development and these include ternary complexes of histone protein and liposomes. Besides trial-and-error approaches, the mechanism of the nuclear entry of plasmid DNA, a critical step, has been under intense study. It is anticipated that further advances in the efficiency of direct, non-viral gene transfer will enable its use in clinical settings in the near future.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267844     DOI: 10.1016/s0960-8966(97)00055-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B.

Authors:  J Reiss; C Dorche; B Stallmeyer; R R Mendel; N Cohen; M T Zabot
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

Review 2.  Progress in gene therapy for Duchenne muscular dystrophy.

Authors:  P R Clemens; F J Duncan
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

3.  Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.

Authors:  F Längle-Rouault; V Patzel; A Benavente; M Taillez; N Silvestre; A Bompard; G Sczakiel; E Jacobs; K Rittner
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial.

Authors:  Duncan J Stewart; Michael J B Kutryk; David Fitchett; Michael Freeman; Nancy Camack; Yinghua Su; Anthony Della Siega; Luc Bilodeau; Jeffrey R Burton; Guy Proulx; Sam Radhakrishnan
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.